King's College London NHS Foundation Trust, King's College Hospital, Denmark Hill, London, SE5 9RS, UK.
Imperial College Healthcare NHS Trust , Hammersmith Hospital, Du Cane Road, London, W12 0HS, UK.
Eur J Med Res. 2019 Jul 26;24(1):25. doi: 10.1186/s40001-019-0383-8.
Cardioembolism in paroxysmal atrial fibrillation (PAF) is a preventable cause of transient ischaemic attack (TIA) or ischaemic stroke; however, due to its transient nature, a short-duration Holter monitor may miss a significant proportion of events.
We conducted an open-label randomised controlled trial of cardiac monitoring after a TIA or ischaemic stroke comparing a 14-day ECG monitoring patch (Zio Patch, iRhythm Technologies) with short-duration Holter monitoring for the detection of PAF. The primary outcome was the detection of one or more episodes of ECG-documented PAF lasting at least 30 s within 90 days in each of the study arms. A budget impact analysis from the healthcare perspective was performed.
From February 2016 through February 2017, 43 (76.8%) of the 56 patients assigned to the patch-based monitoring group and 47 (78.3%) of the 60 patients assigned to short-duration Holter monitoring group had successful monitor placement with 90 days of follow-up. Of the 26 protocol failures between the two groups, 23 (88.5%) were due to patient refusal for outpatient short-duration ECG monitor placement, whilst only 1 (3.8%) was due unsuccessful ZioPatch placement. The rate of detection of PAF at 90 days was 16.3% in the patch-based monitoring group (seven patients) compared to 2.1% in the short-duration Holter monitoring group (1 patient), with an odds ratio of 8.9 (95% CI 1.1-76.0; P = 0.026). An economic model demonstrated that implementation of the Zio Patch service would result in 10.8 more strokes avoided per year compared to current practice with Holter monitoring with an associated yearly saving in direct medical costs of £113,630, increasing to £162,491 over 5 years.
Early, prolonged, patch-based monitoring after an index stroke or TIA is superior to short-duration Holter monitoring in the detection of PAF and likely cost-effective for preventing recurrent strokes. Trial registration http://www.isrctn.com. Unique identifier: ISRCTN 50253271. Registered 21 January 2016.
阵发性心房颤动(PAF)中的心源性栓塞是短暂性脑缺血发作(TIA)或缺血性卒中的可预防病因;然而,由于其短暂的性质,短期动态心电图监测可能会错过很大比例的事件。
我们进行了一项 TIA 或缺血性卒中后心脏监测的开放标签随机对照试验,比较了为期 14 天的心电图监测贴片(Zio Patch,iRhythm Technologies)与短期动态心电图监测,以检测 PAF。主要结局是在每个研究臂中在 90 天内检测到一个或多个持续至少 30 秒的 ECG 记录的 PAF 发作。从医疗保健角度进行了预算影响分析。
从 2016 年 2 月至 2017 年 2 月,在接受基于贴片监测组的 56 名患者中,有 43 名(76.8%)和接受短期动态心电图监测组的 60 名患者中,有 47 名(78.3%)成功放置了监测器,并进行了 90 天的随访。在两组之间的 26 例方案失败中,有 23 例(88.5%)是由于患者拒绝进行门诊短期心电图监测,而只有 1 例(3.8%)是由于 ZioPatch 放置不成功。在基于贴片监测组中,在 90 天的时间里,PAF 的检出率为 16.3%(7 名患者),而在短期动态心电图监测组中为 2.1%(1 名患者),优势比为 8.9(95%CI 1.1-76.0;P=0.026)。经济模型表明,与目前使用动态心电图监测的情况相比,实施 ZioPatch 服务每年可避免 10.8 次中风,每年直接医疗成本节省 113630 英镑,5 年内增加到 162491 英镑。
在指数性卒中和 TIA 后早期、延长的贴片监测优于短期动态心电图监测,在检测 PAF 方面具有优势,并且可能具有成本效益,有助于预防复发性中风。试验注册http://www.isrctn.com。独特标识符:ISRCTN50253271。于 2016 年 1 月 21 日注册。